- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03984136
HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM
The Effectiveness of HIV Results Exchange Mechanism on Promoting Testing Behavior Among Men Who Have Sex With Men: A Cluster Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This will be a two-arm cluster randomized controlled trial. A WeChat-based mini program has been developed to send and receive Center for Disease Control and Prevention certified online HIV results (COHIV). WeChat is the ubiquitous communication and social networking tool in China. We will use the social network method for participant recruitment. A social network consists of one ego and some alters, and in this study a social network will be considered as a cluster. In a social network, ego is the MSM who shares his certified HIV test results with or without exchange mechanism by the WeChat mini program, while alters are recipients of the shared links. So the ego can shares his COHIV with many alters. After an ego shares the certified HIV test result with exchange mechanism (intervention group) or without exchange mechanism (control group) with their WeChat contactors, the people who click the link will be candidate alters in our study. 1020 alters will be recruited as the participants and the randomization would be based on the unit of social network, which means the alters will be randomized into the same group that the ego is in.
Participants in the intervention group will receive his friend's COHIV and can only open it when the participants share their own in exchange. If the participant already has the COHIV, the system will lead the user to send his COHIV to the friend. If the participant does not have the COHIV, the system will guide him to make online appointment at the testing clinic. The participants in the control group will be able to receive and open the friend's COHIV entirely at the friend's discretion without the mandatory exchange requirement. The system will also guide users on how to get an HIV test by making appointments with the MSM friendly clinics in the mini program. Questionnaires are scheduled at baseline, month 3, 6 and 9. Follow-up questionnaires will be delivered through WeChat. The primary outcome is HIV testing rate of the participants in the past three months.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Chun Hao, PhD
- Phone Number: 020-87334892
- Email: haochun@mail.sysu.edu.cn
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510060
- Recruiting
- Lingnan Partner Community Support Centre
-
Contact:
- Jie Lu
- Phone Number: 02013760745376
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged more than18 years old
- Had anal sex with men
- HIV unknown or negative
- Plan to live in Guangzhou for the next year
Exclusion Criteria:
- Cannot complete questionnaire survey due to difficulty in reading or communication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Men will be required to exchange the Center for Disease Control and Prevention certified online HIV results (COHIV) with friends conditionally.
|
A WeChat-based mini program has been developed to send and receive Center for Disease Control and Prevention certified online HIV results (COHIV).
WeChat is the ubiquitous communication and social networking tool in China.
Participants in the intervention group will receive his friend's COHIV only when the participants share their own in exchange.
If the participant already has the COHIV, the system will lead the user to send his COHIV to the friend.
If the participant does not have the COHIV, the system will guide him to make online appointment at the testing clinic.
|
|
Active Comparator: Control group
Men will share the Center for Disease Control and Prevention certified online HIV results (COHIV) with friends freely without conditional exchange requirement.
|
The participants in the control group will be able to receive the friend's Center for Disease Control and Prevention certified online HIV results (COHIV) entirely at the friend's discretion without the mandatory exchange requirement.
The system will also guide users on how to get an HIV test by making appointments with the MSM friendly clinics in the mini program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with self-reported HIV testing in the past three months
Time Frame: Enrollment time
|
Self-reported HIV testing includes any classification of HIV testing, will be measured by self-reported data from online questionnaires.
|
Enrollment time
|
|
Number of participants with self-reported HIV testing in the past three months
Time Frame: 3 months after enrollment
|
Self-reported HIV testing includes any classification of HIV testing, will be measured by self-reported data from online questionnaires.
|
3 months after enrollment
|
|
Number of participants with self-reported HIV testing in the past three months
Time Frame: 6 months after enrollment
|
Self-reported HIV testing includes any classification of HIV testing, will be measured by self-reported data from online questionnaires.
|
6 months after enrollment
|
|
Number of participants with self-reported HIV testing in the past three months
Time Frame: 9 months after enrollment
|
Self-reported HIV testing includes any classification of HIV testing, will be measured by self-reported data from online questionnaires.
|
9 months after enrollment
|
|
Number of participants with self-reported HIV self-testing(HIVST) in the past three months
Time Frame: Enrollment time
|
HIVST will be measured by self-reported data from online questionnaires.
|
Enrollment time
|
|
Number of participants with self-reported HIV self-testing(HIVST) in the past three months
Time Frame: 3 months after enrollment
|
HIVST will be measured by self-reported data from online questionnaires.
|
3 months after enrollment
|
|
Number of participants with self-reported HIV self-testing(HIVST) in the past three months
Time Frame: 6 months after enrollment
|
HIVST will be measured by self-reported data from online questionnaires.
|
6 months after enrollment
|
|
Number of participants with self-reported HIV self-testing(HIVST) in the past three months
Time Frame: 9 months after enrollment
|
HIVST will be measured by self-reported data from online questionnaires.
|
9 months after enrollment
|
|
Number of participants with clinic-based HIV testing services (HTS) in the past three months
Time Frame: Enrollment time
|
Clinic-based HTS will be measured by the objectively recorded HIV testing at the HIV clinic which will be captured real-time through the computer system.
|
Enrollment time
|
|
Number of participants with clinic-based HIV testing services (HTS) in the past three months
Time Frame: 3 months after enrollment
|
Clinic-based HTS will be measured by the objectively recorded HIV testing at the HIV clinic which will be captured real-time through the computer system.
|
3 months after enrollment
|
|
Number of participants with clinic-based HIV testing services (HTS) in the past three months
Time Frame: 6 months after enrollment
|
Clinic-based HTS will be measured by the objectively recorded HIV testing at the HIV clinic which will be captured real-time through the computer system.
|
6 months after enrollment
|
|
Number of participants with clinic-based HIV testing services (HTS) in the past three months
Time Frame: 9 months after enrollment
|
Clinic-based HTS will be measured by the objectively recorded HIV testing at the HIV clinic which will be captured real-time through the computer system.
|
9 months after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with sexually transmitted diseases (STDs) testing
Time Frame: Enrollment time
|
Sexually transmitted diseases (STDs) testing will be measured by self-reported data from online questionnaires and registered data in the HIV testing system.
|
Enrollment time
|
|
Number of participants with sexually transmitted diseases (STDs) testing
Time Frame: 3 months after enrollment
|
Sexually transmitted diseases (STDs) testing will be measured by self-reported data from online questionnaires and registered data in the HIV testing system.
|
3 months after enrollment
|
|
Number of participants with sexually transmitted diseases (STDs) testing
Time Frame: 6 months after enrollment
|
Sexually transmitted diseases (STDs) testing will be measured by self-reported data from online questionnaires and registered data in the HIV testing system.
|
6 months after enrollment
|
|
Number of participants with sexually transmitted diseases (STDs) testing
Time Frame: 9 months after enrollment
|
Sexually transmitted diseases (STDs) testing will be measured by self-reported data from online questionnaires and registered data in the HIV testing system.
|
9 months after enrollment
|
|
Sexual behaviors in the past three months
Time Frame: Enrollment time
|
High-risk and protective sexual behaviors include regular or casual sex partners; request for disclosure of HIV status before sex in the past 3 months; unprotected anal intercourse (UAI) with sex partners in the past 3 months; HIV testing service appointment and HIV test results, will be measured by self-reported data from online questionnaires and the routinely collect data in the HIV testing service system.
|
Enrollment time
|
|
Sexual behaviors in the past three months
Time Frame: 3 months after enrollment
|
High-risk and protective sexual behaviors include regular or casual sex partners; request for disclosure of HIV status before sex in the past 3 months; unprotected anal intercourse (UAI) with sex partners in the past 3 months; HIV testing service appointment and HIV test results, will be measured by self-reported data from online questionnaires and the routinely collect data in the HIV testing service system.
|
3 months after enrollment
|
|
Sexual behaviors in the past three months
Time Frame: 6 months after enrollment
|
High-risk and protective sexual behaviors include regular or casual sex partners; request for disclosure of HIV status before sex in the past 3 months; unprotected anal intercourse (UAI) with sex partners in the past 3 months; HIV testing service appointment and HIV test results, will be measured by self-reported data from online questionnaires and the routinely collect data in the HIV testing service system.
|
6 months after enrollment
|
|
Sexual behaviors in the past three months
Time Frame: 9 months after enrollment
|
High-risk and protective sexual behaviors include regular or casual sex partners; request for disclosure of HIV status before sex in the past 3 months; unprotected anal intercourse (UAI) with sex partners in the past 3 months; HIV testing service appointment and HIV test results, will be measured by self-reported data from online questionnaires and the routinely collect data in the HIV testing service system.
|
9 months after enrollment
|
|
HIV testing norms
Time Frame: Enrollment time
|
HIV testing norms are measured using six survey items that are each on a four-point Likert scale in online surveys.
All six items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree).
The mean score is reported, ranged from 1 to 4. Higher values indicate less positive HIV testing social norms.
|
Enrollment time
|
|
HIV testing norms
Time Frame: 3 months after enrollment
|
HIV testing norms are measured using six survey items that are each on a four-point Likert scale in online surveys.
All six items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree).
The mean score is reported, ranged from 1 to 4. Higher values indicate less positive HIV testing social norms.
|
3 months after enrollment
|
|
HIV testing norms
Time Frame: 6 months after enrollment
|
HIV testing norms are measured using six survey items that are each on a four-point Likert scale in online surveys.
All six items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree).
The mean score is reported, ranged from 1 to 4. Higher values indicate less positive HIV testing social norms.
|
6 months after enrollment
|
|
HIV testing norms
Time Frame: 9 months after enrollment
|
HIV testing norms are measured using six survey items that are each on a four-point Likert scale in online surveys.
All six items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree).
The mean score is reported, ranged from 1 to 4. Higher values indicate less positive HIV testing social norms.
|
9 months after enrollment
|
|
HIV stigma
Time Frame: Enrollment time
|
HIV stigma will be measured by a 7-item version of the HIV stigma scale, designed to measure the extent to which participants anticipated negative interpersonal and interpersonal consequences were they to contract HIV in the future.
All seven items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree).
The mean score is reported, ranged from 1 to 4. Higher values indicate greater stigma.
|
Enrollment time
|
|
HIV stigma
Time Frame: 3 months after enrollment
|
HIV stigma will be measured by a 7-item version of the HIV stigma scale, designed to measure the extent to which participants anticipated negative interpersonal and interpersonal consequences were they to contract HIV in the future.
All seven items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree).
The mean score is reported, ranged from 1 to 4. Higher values indicate greater stigma.
|
3 months after enrollment
|
|
HIV stigma
Time Frame: 6 months after enrollment
|
HIV stigma will be measured by a 7-item version of the HIV stigma scale, designed to measure the extent to which participants anticipated negative interpersonal and interpersonal consequences were they to contract HIV in the future.
All seven items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree).
The mean score is reported, ranged from 1 to 4. Higher values indicate greater stigma.
|
6 months after enrollment
|
|
HIV stigma
Time Frame: 9 months after enrollment
|
HIV stigma will be measured by a 7-item version of the HIV stigma scale, designed to measure the extent to which participants anticipated negative interpersonal and interpersonal consequences were they to contract HIV in the future.
All seven items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree).
The mean score is reported, ranged from 1 to 4. Higher values indicate greater stigma.
|
9 months after enrollment
|
|
Risk perception of HIV in MSM community
Time Frame: Enrollment time
|
Risk perception of HIV in MSM community will be measured by self-perceived HIV prevalence in the circle.
|
Enrollment time
|
|
Risk perception of HIV in MSM community
Time Frame: 3 months after enrollment
|
Risk perception of HIV in MSM community will be measured by self-perceived HIV prevalence in the circle.
|
3 months after enrollment
|
|
Risk perception of HIV in MSM community
Time Frame: 6 months after enrollment
|
Risk perception of HIV in MSM community will be measured by self-perceived HIV prevalence in the circle.
|
6 months after enrollment
|
|
Risk perception of HIV in MSM community
Time Frame: 9 months after enrollment
|
Risk perception of HIV in MSM community will be measured by self-perceived HIV prevalence in the circle.
|
9 months after enrollment
|
|
HIV report delivery
Time Frame: Enrollment time
|
HIV report delivery includes the proportion of Egos who forward and read their reports; the proportion of Alters who receive and read egos' reports; the proportion of alters who get their own HIV reports; the proportion of forwarded report usage among MSM and the satisfaction of online HIV report service.
These data will be collected by the WeChat-based data portal.
|
Enrollment time
|
|
HIV report delivery
Time Frame: 3 months after enrollment
|
HIV report delivery includes the proportion of Egos who forward and read their reports; the proportion of Alters who receive and read egos' reports; the proportion of alters who get their own HIV reports; the proportion of forwarded report usage among MSM and the satisfaction of online HIV report service.
These data will be collected by the WeChat-based data portal.
|
3 months after enrollment
|
|
HIV report delivery
Time Frame: 6 months after enrollment
|
HIV report delivery includes the proportion of Egos who forward and read their reports; the proportion of Alters who receive and read egos' reports; the proportion of alters who get their own HIV reports; the proportion of forwarded report usage among MSM and the satisfaction of online HIV report service.
These data will be collected by the WeChat-based data portal.
|
6 months after enrollment
|
|
HIV report delivery
Time Frame: 9 months after enrollment
|
HIV report delivery includes the proportion of Egos who forward and read their reports; the proportion of Alters who receive and read egos' reports; the proportion of alters who get their own HIV reports; the proportion of forwarded report usage among MSM and the satisfaction of online HIV report service.
These data will be collected by the WeChat-based data portal.
|
9 months after enrollment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Chun Hao, PhD, Sun Yat-sen University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Slow Virus Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- No.054 of ethic committee
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV/AIDS
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of Massachusetts, BostonCompleted
-
Stanford UniversityJanssen Services, LLCCompleted
-
ViiV HealthcareJohns Hopkins University; Pfizer; Vanderbilt University; University of North Carolina...Completed
-
Medical College of WisconsinCompleted
-
Emory UniversityCompleted
-
Rhode Island HospitalUnknown
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Lampiris, Harry W., M.D.AbbottUnknown
Clinical Trials on COHIV with exchange mechanism
-
TriCity Research CenterMedtronicEnrolling by invitationDiabetic Peripheral Neuropathic Pain (DPN)United States
-
University of Applied Sciences for Health Professions...Recruiting
-
OrthoCarolina Research Institute, Inc.Emory University; University of California, San Francisco; Midwest Orthopaedics...WithdrawnPeriprosthetic Infection Total Hip ArthoplastyUnited States
-
Saglik Bilimleri UniversitesiKarabuk UniversityCompleted
-
CHU de Quebec-Universite LavalCompletedEpiretinal MembraneCanada
-
National Medical Research Center for Rehabilitation...Pirogov Russian National Research Medical University; DNKOM LLC; The Orenburg...RecruitingCardiovascular Diseases | Nervous System Diseases | Urologic Diseases | Diabetes | Neuromuscular Diseases | Hypercholesterolemia | Gout | Hyperbilirubinemia | Hyper IgE Syndrome | Hyper-LDL-cholesterolemia | Hyper Beta Lipoproteinemia | Hyper Eosinophilic SyndromeRussian Federation
-
Evergreen General Hospital, TaiwanCentre hospitalier de l'Université de Montréal (CHUM); King Chulalongkorn Memorial... and other collaboratorsRecruitingColon Adenomas | Serrated Lesion | Sessile Colonic Polyp | Sessile Serrated LesionThailand, Canada, Italy, Taiwan
-
University of CagliariFondazione SardegnaActive, not recruiting
-
Prof. Dr. Cemil Tascıoglu Education and Research...CompletedPseudoarthrosis of Bone | Implant Breakage
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Mastectomy; LymphedemaHungary